Biotechnology – Study Notes for BPT Biology
1. Simple Explanation
Biotechnology is the application of biological systems, living organisms, or derivatives to develop or make useful products. In its simplest form, it is the engineering of living systems to solve problems in medicine, agriculture, industry, and environmental science.
Think of it as a toolbox that lets scientists:
- Modify DNA to create new traits.
- Grow cells in culture to produce medicines or enzymes.
- Use microbes to break down waste or produce biofuels.
2. Key Points
| # | Concept | Why it matters for BPT | Typical Examples |
|---|---|---|---|
| 1 | DNA & Gene Cloning | Understanding gene manipulation helps in pain‑relief drug production. | Recombinant insulin, growth factors for wound healing. |
| 2 | Recombinant DNA Technology | Enables production of therapeutic proteins in large quantities. | Recombinant human growth hormone (rhGH). |
| 3 | Cell & Tissue Culture | Culturing cells is central to regenerative medicine and drug testing. | Fibroblast cultures for skin grafts. |
| 4 | CRISPR/Cas‑9 | Precise gene editing offers new treatment avenues for genetic disorders. | Potential correction of cystic fibrosis mutations. |
| 5 | Transgenic Organisms | Creating animals or plants with desired traits can improve nutrition or drug delivery. | GM soybeans, transgenic goats producing antithrombin. |
| 6 | Biopharmaceuticals | Biotech drugs are often more specific and less toxic than traditional drugs. | Monoclonal antibodies for rheumatoid arthritis. |
| 7 | Phytoremediation & Biofuels | Using plants or microbes to clean up pollutants or produce energy. | Algae biofuel, willow for carbon sequestration. |
| 8 | Ethical & Safety Issues | Ensuring responsible use of genetic technologies. | GMO labeling, gene‑drive concerns. |
3. Worked Example
Problem
You are asked to produce recombinant human insulin for a diabetic patient using E. coli.
Step‑by‑Step
-
Identify the Gene
- Insulin gene (INS) located on chromosome 11 in humans.
- Sequence known: 114 bp coding for 51 aa.
-
Clone the Gene into a Vector
- Choose a plasmid vector (e.g., pET‑21b).
- Insert the INS gene downstream of a strong promoter (T7).
- Add a ribosome binding site for efficient translation.
-
Transform E. coli
- Introduce recombinant plasmid into competent E. coli BL21(DE3) cells.
- Select on antibiotic (e.g., ampicillin).
-
Induce Protein Expression
- Grow culture to OD600 ≈ 0.6.
- Add IPTG (isopropyl β‑D‑thiogalactoside) to trigger T7 promoter.
- Incubate 3–4 h at 37 °C.
-
Harvest & Purify
- Lyse cells (sonication).
- Use affinity chromatography (His‑tag) to isolate insulin.
- Refold disulfide bonds if necessary.
-
Validate
- SDS‑PAGE to check size (~51 aa).
- Mass spectrometry to confirm identity.
- ELISA to quantify activity.
-
Formulate
- Buffer it in saline, add stabilizers, fill vials.
-
Quality Control
- Test sterility, endotoxin level (<0.5 EU/ml), and potency.
Result
You obtain a cost‑effective, biologically active insulin ready for therapeutic use.
4. Quick Revision Summary
| Topic | Take‑away |
|---|---|
| DNA & Gene Cloning | DNA fragments inserted into vectors → new traits |
| Recombinant DNA | Produces high‑yield therapeutic proteins |
| Cell/Tissue Culture | Basis for regenerative therapies |
| CRISPR/Cas‑9 | Precise gene editing tool |
| Transgenic Organisms | GM crops, drug‑producing animals |
| Biopharmaceuticals | Targeted, less toxic medicines |
| Phytoremediation & Biofuels | Environmental cleanup & sustainable energy |
| Ethics & Safety | GMO regulations, bio‑security |
Use this cheat‑sheet to quickly recall how biotechnology underpins modern physiotherapy—especially in drug production, tissue engineering, and regenerative medicine.